Lacarya Scott, CFA

Lacarya Scott, CFA has a diverse and extensive work experience in various roles and industries. Lacarya is currently a Founding Partner at Tungsten Advisors, an investment banking firm specializing in healthcare and technology companies. Lacarya co-founded iPill Dispenser in 2020. Prior to these ventures, they were a Vice President at Ferghana Partners from 2017 to 2018. Lacarya also served as the President and COO of Ligandal in 2016-2017. Lacarya held the position of VP BD at Liposeuticals from 2012 to 2015 and at Mesoblast Limited from 2011 to 2014. Lacarya has also worked as a Managing Director at Jermyn Street Capital LLC from 2008 to 2011 and as an Associate at Caxton Associates from 2006 to 2008. Their earlier experience includes an Associate role at Invitrogen from 2004 to 2006.

Lacarya Scott, CFA, obtained a Bachelor of Arts degree in Biochemistry, Biophysics, and Molecular Biology from Princeton University, where they studied from 1993 to 1997. Subsequently, they pursued a Master of Science degree in Biological Chemistry from New York University, completing their studies from 2000 to 2003. Lacarya furthered their education by earning an MBA degree in Finance from The Wharton School and a Master of Science degree in Engineering Biotechnology from the University of Pennsylvania, both attained between 2002 and 2004. Lacarya also holds various certifications, including the Series 63, Series 79 (Investment Banking Representative), and the Securities Industry Essentials, obtained in 2019. Additionally, they have obtained the Chartered Financial Analyst (CFA) designation, with specific details regarding the month and year of attainment not provided.